Brain scans reveal hidden effects of childhood cancer treatment

NCT ID NCT03208387

Ongoing Knowledge-focused Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study looks at how surviving a pediatric brain tumor affects thinking and behavior. Researchers will use brain scans to examine brain structure in children who have completed treatment. The goal is to better understand the long-term cognitive challenges these survivors may face.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify brain changes linked to cognitive problems in pediatric brain tumor survivors, guiding future support strategies.
What could go wrong: This is a small pilot study with only 42 participants, focused on feasibility. It may not produce definitive results or directly lead to treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm cerebellar vermis medulloblastoma childhood malignant neoplasm low-grade astrocytoma medulloblastoma neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN TUMOR PEDIATRIC BRAIN TUMOR PEDIATRIC CANCER

Contacts and locations

Locations

Columbia University

New York, New York, 10032, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
Seattle Children's Hospital

Seattle, Washington, 98105, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.